Viewing Study NCT03201757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2025-12-27 @ 12:57 PM
Study NCT ID: NCT03201757
Status: COMPLETED
Last Update Posted: 2024-09-26
First Post: 2017-06-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
Sponsor: Alkermes, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Schizophreniform Disorder View
None Bipolar I Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alkermes View
None ALKS 3831 View
None Olanzapine View
None Samidorphan View
None Schizophrenia View
None Schizophreniform View
None Bipolar I View